Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
7,254,615
-
Total 13F shares
-
4,328,239
-
Share change
-
+128,247
-
Total reported value
-
$21,120,201
-
Put/Call ratio
-
0%
-
Price per share
-
$4.88
-
Number of holders
-
40
-
Value change
-
+$284,256
-
Number of buys
-
12
-
Number of sells
-
19
Institutional Holders of Kezar Life Sciences, Inc. - Common Stock, par value $0.001 per share (KZR) as of Q1 2025
As of 31 Mar 2025,
Kezar Life Sciences, Inc. - Common Stock, par value $0.001 per share (KZR) was held by
40 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,328,239 shares.
The largest 10 holders included
TANG CAPITAL MANAGEMENT LLC, SUVRETTA CAPITAL MANAGEMENT, LLC, Avidity Partners Management LP, BML Capital Management, LLC, VANGUARD GROUP INC, ORBIMED ADVISORS LLC, ADAR1 Capital Management, LLC, ACADIAN ASSET MANAGEMENT LLC, Peapod Lane Capital LLC, and SPHERA FUNDS MANAGEMENT LTD..
This page lists
40
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.